UGT1A1 and neutropenia: In 177 Japanese patients treated with irinotecan-including chemotherapy, a homozygous or double heterozygous genotype for UGT1A1*6 and UGT1A1*28 (*6/*6, *28/*28 or *6/*28) was significantly associated with severe neutropenia (Minami et al, 2007).